CHTR vs NPCE · P/E 11, rev $55.09B vs rev $79.9M
Charter Communications Inc (CHTR) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CHTR and NPCE stock pages for the full models.
Not investment advice.